Compounds > (endo-n-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2-3-dihydro-3-isopropyl-2-oxo-1h-benzimidazol-1-carboxamide

(endo-n-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2-3-dihydro-3-isopropyl-2-oxo-1h-benzimidazol-1-carboxamide and Parkinsonian-Disorders

(endo-n-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2-3-dihydro-3-isopropyl-2-oxo-1h-benzimidazol-1-carboxamide has been researched along with Parkinsonian-Disorders* in 1 studies

Other Studies

1 other study(ies) available for (endo-n-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2-3-dihydro-3-isopropyl-2-oxo-1h-benzimidazol-1-carboxamide and Parkinsonian-Disorders

ArticleYear
Activation and blockade of serotonin
    Neurological research, 2019, Volume: 41, Issue:7

    Topics: Animals; Benzimidazoles; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dopamine; Dose-Response Relationship, Drug; Habenula; Indoles; Male; Maze Learning; Memory, Short-Term; Microinjections; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists; Substantia Nigra; Sulfonamides

2019